IP Library › Granted Patent US 8,889,881
Granted Patent B2
US 8,889,881 · App. 13/984,567 · Granted Nov 18, 2014

Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor

Inventors: Hae Young Chung (Busan, KR); Min Hi Park (Busan, KR); Young Mi Ha (Busan, KR); Yu Kyeong Han (Busan, KR); Ji Young Park (Busan, KR); Yun Jung Park (Busan, KR); Jin Ah Kim (Busan, KR); Ji Yeon Lee (Gyeongsangnam-do, KR); Yu Min Song (Busan, KR); Hyung Ryong Moon (Busan, KR)
Assignee: Pusan National University Industry —University Cooperation Foundation
A61K8/49A61K31/426C07D235/18C07D277/06A61K2800/78A61K8/4946A61Q19/02C07D277/66A61Q19/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,889,881
App. No.
13/984,567
Granted
Nov 18, 2014
Kind
B2
Abstract

Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.

Claims (5)

1. A skin-whitening method, comprising:

administering to a subject a compound according to Formula 10 in a range of 0.001 to 100 mg/kg,

wherein X is any one of chlorine, and trifluoromethyl, and Y is any one of hydrogen and methoxy.

2. A skin-whitening method, comprising:

administering to a subject at least one of 2-methyl-2-(4-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)phenoxy)propanoic acid (Compound 98) and 2-(4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy)-2-methylpropanoic acid (Compound 99) in a range of 0.001 to 100 mq/kq.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2013
From: CHUNG, HAE YOUNG; PARK, MIN HI; HA, YOUNG MI; HAN, YU KYEONG; PARK, JI YOUNG; PARK, YUN JUNG; KIM, JIN AH; LEE, JI YEON; SONG, YU MIN; MOON, HYUNG RYONG
To: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
Reel/Frame 030994/0369 →
Priority Claims (1)
KR 10-2011-0011544 · Feb 9, 2011 · national
Continuity (1)
Related Publication 20140037564A1 · Feb 6, 2014